Trial Profile
A phase I trial to assess swallowed versus chewed raltegravir in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Nov 2015
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 24 Nov 2015 New trial record